IP Verse

Egis Gygyszergyr Nyilvnosan Mkd Rszvnytrsasg competitive analysis

Loading summary...

Latest patents of Egis Gygyszergyr Nyilvnosan Mkd Rszvnytrsasg opposed by its competitors

Explore Egis Gygyszergyr Nyilvnosan Mkd Rszvnytrsasg's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2359815
Jan 8, 2020Compositions Comprising Amlodipine And Bisoprolol1
EP2344141
May 1, 2019Compositions Comrrising Amlodipine And Bisoprolol1

Latest publications and patents of Egis Gygyszergyr Nyilvnosan Mkd Rszvnytrsasg New

Explore the latest publications and patents granted to Egis Gygyszergyr Nyilvnosan Mkd Rszvnytrsasg, showcasing their recent innovations and technological advancements.

Last updated on: Oct 20, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Egis Gygyszergyr Nyilvnosan Mkd Rszvnytrsasg

EP2359815
Jan 8, 2020Compositions Comprising Amlodipine And BisoprololRevoked
EP2344141
May 1, 2019Compositions Comrrising Amlodipine And BisoprololRevoked

Latest PTAB cases involving Egis Gygyszergyr Nyilvnosan Mkd Rszvnytrsasg

Discover the latest PTAB cases involving Egis Gygyszergyr Nyilvnosan Mkd Rszvnytrsasg, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Egis Gygyszergyr Nyilvnosan Mkd Rszvnytrsasg with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
EGIS GYGYSZERGYR NYILVNOSAN MKD RSZVNYTRSASG - 2 - -
KRKA286 - -